<DOC>
	<DOCNO>NCT00191113</DOCNO>
	<brief_summary>A randomize , control trial girl Turner syndrome least 7 year old young 13 study entry , determine efficacy safety Humatrope ( somatropin ) treatment promote linear growth final height .</brief_summary>
	<brief_title>Somatropin Treatment Final Height Turner Syndrome</brief_title>
	<detailed_description>A randomize , control trial Humatrope ( somatropin ) treatment girl Turner syndrome least 7 year old young 13 study entry . Core study objective determine efficacy Humatrope promote linear growth final height girl Turner syndrome , assess safety treatment . Core study completion criterion ( protocol final height ) patient height velocity &lt; 2 cm per year bone age 14 year great . Addendum 1 provide option Humatrope treatment patient randomize Control arm Core study discontinue study December 19 , 1997 . Addendum 2 objective : 1 ) collect true final height data ; 2 ) evaluate hearing , tympanic membrane function specific area interest respect safety growth hormone therapy Turner syndrome ; 3 ) evaluate pancreatic beta cell function ( glucose metabolism ) patient previously enrol Core study . Addendum 3 objective determine parental origin retain X chromosome appropriate subset patient currently previously enrol Core study , determine whether parental origin hold predictive value spontaneous growth response growth hormone therapy .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>girl Turner syndrome prepubertal , Tanner stage I breast height velocity le 6 cm/year height less equal tenth percentile sex age general population least 6 month ( preferably 12 month ) accurate height measurement available calculation prestudy height velocity thyroxine deficient , receive replacement therapy , six month prior enrollment normal thyroid function test prior treatment growth hormone presence Y component karyotype gonad situ diabetes mellitus</criteria>
	<gender>Female</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>syndrome</keyword>
	<keyword>Turner</keyword>
	<keyword>Turner 's</keyword>
	<keyword>height</keyword>
	<keyword>growth</keyword>
	<keyword>growth hormone</keyword>
	<keyword>somatropin</keyword>
	<keyword>short stature</keyword>
	<keyword>short</keyword>
	<keyword>hearing</keyword>
	<keyword>glucose metabolism</keyword>
</DOC>